Search results
EXCLUSIVE: Enosis Therapeutics & Ovid Clinics Develop World's First In-Clinic VR For Psychedelic...
Benzinga via Yahoo Finance· 2 years agoAustralian biotech psychedelics start-up Enosis Therapeutics has partnered with Berlin-based...
Ovid Therapeutics Inc.'s (NASDAQ:OVID) hedge funds investors lost 12% last week but have benefitted...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Institutions' substantial holdings in Ovid Therapeutics implies that they have...
Ovid Therapeutics (OVID) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 1 year agoOvid Therapeutics (OVID) might move higher on growing optimism about its earnings prospects, which...
Ovid Therapeutics (NASDAQ:OVID) shareholders have endured a 73% loss from investing in the stock...
Simply Wall St. via Yahoo Finance· 1 year agoOvid Therapeutics Inc. (NASDAQ:OVID) shareholders should be happy to see the share price up 28% in...
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 1 month agoOvid Therapeutics (OVID) possesses the right combination of the two key ingredients for a likely...
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 3 weeks agoOvid Therapeutics (OVID) delivered earnings and revenue surprises of 26.09% and 40.95%,...
Owning 31% shares,hedge funds owners seem interested in Ovid Therapeutics Inc. (NASDAQ:OVID),
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significantly high institutional ownership implies Ovid Therapeutics' stock price is...
Is Ovid Therapeutics (NASDAQ:OVID) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 2 years agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying
Simply Wall St. via Yahoo Finance· 3 months agoLast week, Ovid Therapeutics Inc. (NASDAQ:OVID) insiders, who had purchased shares in the previous...
We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 2 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...